| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9383 |
| Human Intestinal Absorption | HIA+ | 0.9310 |
| Caco-2 Permeability | Caco2- | 0.6100 |
| P-glycoprotein Substrate | Non-substrate | 0.7574 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9489 |
| Non-inhibitor | 0.9432 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9236 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5160 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.5856 |
| CYP450 2D6 Substrate | Non-substrate | 0.8164 |
| CYP450 3A4 Substrate | Non-substrate | 0.5896 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8529 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9972 |
| Non-inhibitor | 0.9289 |
| AMES Toxicity | Non AMES toxic | 0.7181 |
| Carcinogens | Non-carcinogens | 0.6535 |
| Fish Toxicity | Low FHMT | 0.6448 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6899 |
| Honey Bee Toxicity | Low HBT | 0.6274 |
| Biodegradation | Ready biodegradable | 0.7060 |
| Acute Oral Toxicity | III | 0.5991 |
| Carcinogenicity (Three-class) | Non-required | 0.6945 |